T Cell Sciences, Inc.
24Patents
0Active
24Granted
34Portfolio score
Filing activity: Dec 3, 1985 → Apr 16, 1998
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5436319A | Cell free T cell antigen receptor beta chain and its clinical utilities | Emerging Cross-Sectional Technologies | 65 | Expired |
| US5456909A | Glycoform fractions of recombinant soluble complement receptor 1 (sCR1) having extended half-lives in vivo | Human Necessities | 64 | Expired |
| US5212071A | Nucleic acids encoding a human C3b/C4b receptor (CR1) | Emerging Cross-Sectional Technologies | 61 | Expired |
| US5858969A | Therapeutic methods employing sialylated glycoforms of soluble complement receptor 1 (SCR 1) | Human Necessities | 52 | Expired |
| US5976540A | Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions | Human Necessities | 46 | Expired |
| US5856300A | Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions | Human Necessities | 42 | Expired |
| US5472939A | Method of treating complement mediated disorders | Human Necessities | 42 | Expired |
| US5223426A | Monoclonal antibodies reactive with defined regions of the T-cell antigen receptor | Emerging Cross-Sectional Technologies | 40 | Expired |
| US5552300A | T cell antigen receptor V region proteins and methods of preparation thereof | Human Necessities | 37 | Expired |
| US5856297A | Human C3b/C4b receptor (CR1) | Human Necessities | 35 | Expired |
| US5256642A | Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof | Human Necessities | 34 | Expired |
| US4845026A | Assay systems for detecting cell-free T cell antigen receptor related molecules and the clinical utilities of the assays | Emerging Cross-Sectional Technologies | 26 | Expired |
| US5006459A | Therapeutic and diagnostic methods using soluble T cell surface molecules | Emerging Cross-Sectional Technologies | 20 | Expired |
| US5185250A | Human .gamma., .delta.T cell antigen receptor polypeptides and nucleic acids | Chemistry; Metallurgy | 19 | Expired |
| US5840858A | Protein purification using immobilized metal affinity chromatography for complement receptor proteins | Chemistry; Metallurgy | 15 | Expired |
| US5024940A | Nucleic acids encoding the delta chain of the T cell antigen receptor | Chemistry; Metallurgy | 14 | Expired |
| US5173499A | Compounds which inhibit complement and/or suppress immune activity | Chemistry; Metallurgy | 8 | Expired |
| US5506247A | Compounds that inhibit complement and/or suppress immune activity | Chemistry; Metallurgy | 8 | Expired |
| US5340921A | .GAMMA., .delta.T cell receptor and methods and detection | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5366986A | Compounds which inhibit complement and/or suppress immune activity | Human Necessities | 5 | Expired |
| US5601822A | .gamma., .delta. T cell receptor and methods for detection | Emerging Cross-Sectional Technologies | 4 | Expired |
| US5401767A | Compounds which inhibit complement and/or suppress immune activity | Chemistry; Metallurgy | 3 | Expired |
| US5808109A | Compounds that inhibit complement and/or suppress immune activity | Chemistry; Metallurgy | 2 | Expired |
| US5656659A | Compounds which inhibit complement and/or suppress immune activity | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.